Abstract
A lectin that can specifically bind to O-acetylsialic acids, found in glycoproteins and gangliosides, was purified to homogeneity from a crab Cancer antennarius (crab lectin) (Ravindranath, M. H., Higa, H. H., Cooper, E. L., and Paulson, J. C. (1985) J. Biol. Chem. 260, 8850-8856; Correction (1986) J. Biol. Chem. 261, 1983; Ravindranath, M. H., and Paulson, J. C. (1987) Methods Enzymol. 138, 520-527). We tested lectin binding to human melanoma cell lines to identify O-acetylsialylated gangliosides on the melanoma cell surface. The highest degree of binding of the crab lectin was demonstrated on a melanoma cell line, UCLASO-M25. To confirm that the binding was due to O-acetylsialic acid in the alkali-labile gangliosides, the gangliosides were isolated and purified from M25 cells and individually coated onto sheep asialoerythrocytes, which served as targets in an agglutination assay using the lectin. The crab lectin agglutinated the asialo-sheep erythrocytes coated with alkali-labile gangliosides, but the lectin failed to agglutinate the asialoerythrocytes coated with GM3, GD3, and base-treated gangliosides. Subsequently, the purified alkali-labile M25 ganglioside was base-treated and applied to TLC, and we found that it was converted to a slower migrating species identical to the disialolactosylceramide (GD3). These results indicate that O-acetyl GD3 expressed on the melanoma cell surface is recognized by the lectin. Because O-acetyl GD3 is not expressed on human normal tissues, we examined the capability of O-acetyl GD3 to induce immune responses in man. Sera from patients with melanoma were tested against M25 cells in an immuneadherence assay, and those positive to the M25 cell line were further tested for specificity to O-acetyl gangliosides. The presence of autoantibodies to O-acetyl-GD3 in melanoma sera was confirmed by blocking of the antigen sites on M25 cells by the lectin or preabsorption of the sera with erythrocytes bearing O-acetyl gangliosides. The data provide evidence that O-acetyl-GD3 may represent an important tumor marker for detection and treatment of human melanoma.
Highlights
From the Diuision of Surgical Oncology,Armand Hammer Laboratories, John Wayne Cancer Clinic, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, Los Angeles, California 90024 and the $Departmentof Biological Chemistry, UCLA, Los Angeles, California 90024
Binding of Crab Lectin on 0-Acetylsialic Acid Containing Glycolipids-In a n earlier report, we showed crab lectin can bind to 0-acetylsialicacid containing glycoproteins [1,2, 11]
Binding of '251-~rab lectin thoorse and mouse erythrocytes was inhibited by BSM, a sialoglycoprotein rich in O-acetylsialic acids (Table I)
Summary
Binding of Crab Lectin on 0-Acetylsialic Acid Containing Glycolipids-In a n earlier report, we showed crab lectin can bind to 0-acetylsialicacid containing glycoproteins [1,2, 11]. A high correlation was observed between1251-crablectin binding and the hemagglutinationtiters obtained with crab lectin for erythrocytes from different species (Table I). Binding of '251-~rab lectin thoorse and mouse erythrocytes was inhibited by BSM, a sialoglycoprotein rich in O-acetylsialic acids (Table I). Inhibition kinetics data showed that 70 pmol of 0-acetylsialic acids in BSM was sufficient for 50% inhibition of lectin binding t o horse erythrocytes (Fig. 2 ). A 60-fold drop in inhibitory potency was observed when the sialic acids in mucin (base-treated BSM andOSM) were not 0-acetylated. Both of these mucins have a similar sialicacid (Sia)contentand identical oligosaccharide sequence (Sia-a2,6-PGalNAc-Thr/Se(2r7),). We first tested the ability of the crab lectin to bind to such 0-acegtyanl gliosides using horse eryth-
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
